In response to fast-turnaround funding opportunities, collaborations have been forming across the country to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disparities. Here we describe the process, notes from the field, and evaluation results from a new collaboration involving multiple partners, formed in October 2020 in New York City as part of the Rapid Acceleration of Diagnostics initiative. We used the validated Research Engagement Survey Tool to evaluate the partnership. Results can inform future research and improve engagement efforts aimed at reducing SARS-CoV-2 disparities. (. 2022;112(S9):S904-S908. https://doi.org/10.2105/AJPH.2022.307072).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707719 | PMC |
http://dx.doi.org/10.2105/AJPH.2022.307072 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!